New Key Statistics Module, Z-Score and F-Score
NAS:ANIK Key Ratios
| Market Cap $ M | 241.19 |
| Enterprise Value $ M | 215.45 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 271.67 |
| Forward PE Ratio | 181.12 |
| Price/Book | 1.34 |
| Price/Sales | 1.46 |
| Price/Free Cash Flow | 198.77 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 164.00 |
| EPS (TTM) $ | -6.65 |
| Beneish M-Score | -4.33 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -6.88 |
| EV-to-EBITDA | -7.77 |
| PEG | -- |
| Shares Outstanding M | 14.80 |
| Net Margin (%) | -59.40 |
| Operating Margin % | -19.13 |
| Pre-tax Margin (%) | -57.58 |
| Quick Ratio | 3.78 |
| Current Ratio | 5.34 |
| ROA % (ttm) | -35.94 |
| ROE % (ttm) | -45.09 |
| ROIC % (ttm) | -17.86 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.85 |
ANIK Number of Guru Trades
ANIK Volume of Guru Trades
Gurus Latest Trades with NAS:ANIK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ANIK is held by these investors
Total 1
Anika Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ANIK
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers